ASH 2021 Conference Coverage on VuMedi
Avatar

ASH 2021: Addressing Current Questions and Controversies in the Management of Multiple Myeloma

By ASH 2021 Conference Coverage on VuMedi FEATURING Morie Gertz
January 18, 2022
2 Comments
Login to view comments. Click here to Login

Featured Video

17:12
Seagen

Strategies for Managing Toxicities Associated with a First Line Trea…

Feat. A. Forman

Featured Video

19:14
Bristol Myers Squibb Hematology

Study Results of a Treatment Option for AML Patients

Feat. J. Mccloskey, T. Leblanc

Related Content

AUTOPLAY
17:59
Parameswaran Hari

Delivering the Best Initial Treatment for Myeloma: Induction Therapy…

09:50
Nina Shah

Maximizing the Initial Gains in Myeloma Therapy: Consolidation and M…

13:27
Shaji Kumar

Evolving Concepts in the Diagnosis and Risk Stratification of Myeloma

15:31
Parameswaran Hari

Refractory and Relapsing Myeloma - When to Treat and Options Availab…

15:11
Ajay Nooka

Early Relapse: Choosing Among Different Second Line Regimens in Myel…

19:41
Peter Voorhees

Approach to the Patient with Refractory & Multiple Relapsed Mult…

18:44
City of Hope

The Promise of Immunotherapy and Newer Agents in Multiple Myeloma

Feat. A. Krishnan
06:23
Parameswaran Hari

Treating Refractory & Relapsing Myeloma: Current Trends and Reco…

26:57
Saad Usmani

Immune Approaches and Targeted Therapies for Myeloma: The Future

15:10
Krina Patel

Developing CAR T-cells in Multiple Myeloma

03:34
Krina Patel

The Future in Multiple Myeloma: BiTE, CAR T, PI, & IMID

11:51
Memorial Sloan Kettering Cancer Center

Aiming for Minimal Residual Disease Negative Status in all Myeloma P…

Feat. O. Landgren
11:56
Indy Hematology Review

Initial and Maintence Therapy for Multiple Myeloma

Feat. K. Anderson
05:24
Indy Hematology Review

Therapy for Relapsed Multiple Myeloma

Feat. K. Anderson
12:32
Indy Hematology Review

What's New in Immunotherapy and Genomics in Multiple Myeloma?

Feat. K. Anderson
17:47
Dana-Farber Cancer Institute

Relapse Refractory Myeloma and Novel Treatments

Feat. N. S. Raje
15:02
Krina Patel

Clinical Trials in Myeloma in 2018

16:59
Nina Shah

The Future of CAR T Therapies in Myeloma in 2018

05:29
Nina Shah

Future Directions in Myeloma Post-ASCO Discussion

09:02
Maria-Victoria Mateos

FDA Approves Once-Weekly Carfilzomib Regimen for Myeloma